Back
Xvivo Perfusion AB Vs. RH Industry Stock Comparison
Buy
68
XVIPF
Xvivo Perfusion AB
Last Price:
42.90
Seasonality Move:
-0.87%
Buy
77
RH
RH
Last Price:
445.84
Seasonality Move:
-11.77%
Buy
68
Xvivo Perfusion AB (XVIPF)
is a Buy
Is Xvivo Perfusion AB a Buy, Sell or Hold?
- The current Xvivo Perfusion AB [XVIPF] share price is $42.90. The Score for XVIPF is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- XVIPF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
77
RH (RH)
is a Buy
Is RH a Buy, Sell or Hold?
- The current RH [RH] share price is $446.04. The Score for RH is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
- RH is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
XVIPF Stock Price Chart
What is Xvivo Perfusion AB's stock price today?
-
The Xvivo Perfusion AB share price today is $42.90
The current trend is relatively stagnant and XVIPF is experiencing slight buying pressure.
RH Stock Price Chart
XVIPF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.13 | Sell |
Relative Strength Index (14 RSI): | 50.27 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (41.41 - 42.93) | Buy |
Bollinger Bands (100): | (43.16 - 49.68) | Sell |
RH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 19.04 | Buy |
Relative Strength Index (14 RSI): | 73.52 | Buy |
Chaikin Money Flow: | 622425 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (331.42 - 395.84) | Buy |
Bollinger Bands (100): | (268.76 - 360.4) | Buy |
XVIPF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 42.9 | Sell |
20-day SMA: | 42.31 | Buy |
50-day SMA: | 43.86 | Sell |
200-day SMA: | 40.73 | Buy |
8-day EMA: | 42.83 | Buy |
20-day EMA: | 42.71 | Buy |
50-day EMA: | 43.73 | Sell |
200-day EMA: | 40.89 | Buy |
RH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 391.52 | Buy |
20-day SMA: | 372.24 | Buy |
50-day SMA: | 346.48 | Buy |
200-day SMA: | 291.1 | Buy |
8-day EMA: | 397.67 | Buy |
20-day EMA: | 377.44 | Buy |
50-day EMA: | 350.91 | Buy |
200-day EMA: | 305.3 | Buy |
Xvivo Perfusion AB Earnings Growth & XVIPF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
RH Earnings Growth & RH Earnings Dates
- Analysts estimate an earnings decrease this quarter of $1.56 per share, a decrease next quarter of $0.91 per share, a decrease this year of $16.71 per share, and a decrease next year of $2.09 per share.
Xvivo Perfusion AB Technical Analysis
Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
RH Technical Analysis
Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |